Multi-Pronged UK Strategy to Invest $566M in Life Sciences | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UK is making a bold investment in life sciences and biomedical science and industry through several new initiatives announced this week by Prime Minister David Cameron's government, including £360 million ($566 million) in new funding for biomedical research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.